Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

Dr Swagat Dash, HOD & Senior Consultant, Nuclear Medicine and Molecular Theranostics, Sarvodaya Hospital, Faridabad ...

And when the sole therapy available to end-stage prostate cancer patients is Taxotere (docetaxel)—which extends survival by only two-and-a-half months and is so toxic it kills 300 patients ...

“Actinium-225 offered confidence-inspiring results in treating even metastasised and late-stage prostate cancers.” “End-stage cancer patients who thought they had no hope of living were ...

Findings published in the Journal of Clinical Oncology show that one in 20 men with end-stage prostate cancer responded to Keytruda, but although the number who benefited was small, these patients ...

Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures ...